Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers

Immune‐checkpoint inhibitors improve the survival of head and neck squamous cell carcinoma (HNSCC) patients. Although recent studies have demonstrated that the tumor immune microenvironment (TIME) has critical roles in immunotherapy, the precise mechanisms involved are unclear. Therefore, further in...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Susumu, Ogawa, Tetsuya, Sano, Rui, Takahara, Taishi, Inukai, Daisuke, Akira, Satou, Tsuchida, Hiromi, Yoshikawa, Kazuhiro, Ueda, Ryuzo, Tsuzuki, Toyonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293074/
https://www.ncbi.nlm.nih.gov/pubmed/32304268
http://dx.doi.org/10.1111/cas.14422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293074/
https://www.ncbi.nlm.nih.gov/pubmed/32304268
http://dx.doi.org/10.1111/cas.14422

Ejemplares similares